AeroRx Therapeutics
Developer of combination drug therapies intended for respiratory disease treatment. The company develops treatments delivered via nebulization, focusing on older patients with chronic obstructive pulm...
Valuation
$48M
Market implied
Share Price
N/A
Total Raised
$26.8M
Last Round
N/A